Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Danisco US Inc | 45 |
| 2 | Kao Corp | 33 |
| 3 | Novozymes AS | 28 |
| 4 | Procter and Gamble Co | 22 |
| 5 | Honda Motor Co Ltd | 20 |
| 6 | Codexis Inc | 12 |
| 7 | ER Squibb and Sons LLC | 10 |
| 8 | Novo Nordisk AS | 10 |
| 9 | Danisco USA Inc | 8 |
| 10 | Sued Chemie IP GmbH and Co KG | 8 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 375 |
| 2 | C12Y | Enzyme nomenclature (EC numbers) | 277 |
| 3 | C12P | Fermentation, enzyme processes | 172 |
| 4 | Y02E | Climate change mitigation: energy | 136 |
| 5 | C07K | Peptides | 116 |
| 6 | C11D | Detergents, cleaning compositions | 115 |
| 7 | A61K | Medicinal preparations | 99 |
| 8 | A61P | Therapeutic activity (drug indications) | 76 |
| 9 | C12R | 53 | |
| 10 | C07D | Heterocyclic compounds | 37 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWho's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Kunio Ohmiya | Mie University | 4 |
| 2 | Hoon Kim | Sunchon National University | 2 |
| 3 | Jung-Kul Lee | 2 | |
| 4 | Kazuo Sakka | Mie University | 2 |
| 5 | Marimuthu Jeya | 2 |
| 6 | Masayuki Fukumura | Mie University | 2 |
| 7 | Shoichi Shimizu | Nagoya University | 2 |
| 8 | A. Brad Anton | Cornell University | 1 |
| 9 | Akiyoshi Tanaka | Mie University | 1 |
| 10 | Anthony G. Day | University of British Columbia | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| An assay for selective determination of exo-1,4,-β-glucanases in a mixture of cellulolytic enzymes | 1984 | 300 | Enzyme Catalysis and Immobilization |
| Characterization of a Bifunctional Cellulase and Its Structural Gene | 1995 | 111 | Biofuel production and bioconversion |
| Endoglucanase 28 (Cel12A), a new <i>Phanerochaete chrysosporium</i> cellulase | 1999 | 93 | Biofuel production and bioconversion |
| Cellobiose dehydrogenase enhances <i>Phanerochaete chrysosporium</i> cellobiohydrolase I activity by relieving product inhibition | 1998 | 89 | Enzyme Production and Characterization |
| Purification and characterization of an exo-beta-1,4-glucanase from Ruminococcus flavefaciens FD-1 | 1987 | 77 | Enzyme Production and Characterization |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of p-Nitrophenyl cellobioside?
Which companies hold the most patents related to p-Nitrophenyl cellobioside?
What are the primary technical classifications for patents mentioning this compound?
Who is the most prolific author publishing on this compound and its applications?
What research topics are associated with p-Nitrophenyl cellobioside?